|
Sunday
|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
1 event,
Featured
-
Featured
Over the past decade, China's innovative drug pipeline has experienced explosive growth, becoming an integral part of the global pharmaceutical landscape. In 2025, the total value of cross-border licensing for Chinese innovative drugs surpassed $100 billion, doubling the scale of the previous year. Despite this progress, only about 10% of China's new drug pipelines have... |
0 events,
|
1 event,
The Road Ahead: Pharma, Biotech and Healthcare in a Pivotal Year With fresh regulations, and shifting deal trends, 2025 is set to be a transformative year for biopharma and healthcare. At Fierce JPM Week 2025, industry leaders will come together to explore what’s next. From market analysis to an examination of evolving regulatory landscapes, this... |
2 events,
-
Now in its 21st year, the Non-Dilutive Funding Summit (NDFS) is a free, educational event helping life science executives acquire valuable information about non-dilutive funding opportunities for life science R&D. Join hundreds of other innovators in the life science industry to hear the authorities at funding agencies like NIH, BARDA, DoD, and more, discuss their... |
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
1 event,
Featured
Celebrate 25 Years of Innovation at PepTalk Join a vibrant community of scientists, trailblazers, and industry leaders at PepTalk 2026, as we mark 25 years of accelerating breakthroughs in biotherapeutic discovery and development. Renowned as one of the most influential events in protein science, PepTalk is where fresh ideas ignite, collaborations flourish, and next-generation solutions... |
1 event,
|
1 event,
|
1 event,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
